Related Experiment Video
Updated: May 23, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Calcific uremic arteriolopathy on multimodal combination therapy: still unmet goal
Usman Hammawa Malabu1, Valli Manickam, George Kan
1Department of Endocrinology, The Townsville Hospital, 100 Angus Smith Drive, Douglas, QLD 4814, Australia.
Insights
Calcific uremic arteriolopathy (CUA) treatment with multiple agents showed poor outcomes. Despite intensive care, most patients died, indicating a need for further research into effective CUA therapies.
Area of Science:
- Nephrology
- Dermatology
- Vascular Medicine
Background:
- Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a severe condition with high mortality.
- Recent studies suggest potential benefits from single-agent therapies for CUA.
- The efficacy of combination therapeutic agents for CUA remains unclear.
Purpose of the Study:
- To evaluate the clinical outcomes of patients with CUA receiving multimodal treatment.
- To assess the effectiveness of combined therapeutic agents in managing CUA.
Main Methods:
- Retrospective study of end-stage renal failure patients diagnosed with CUA at The Townsville Hospital, Australia (April 2006 - March 2011).
- Analysis of patients treated with a combination of therapies including sodium thiosulphate, hyperbaric oxygen, prednisolone, cinacalcet, parathyroidectomy, intensified hemodialysis, wound care, and antibiotics.
Main Results:
- Six CUA patients (4 female, 2 male) were included in the study.
- Wound healing failed in 3 patients.
- Five out of six patients died, with causes including sepsis (3) and myocardial infarction (2).
Conclusions:
- Multimodal combination therapy for CUA is associated with a poor prognosis.
- Further prospective studies with larger patient populations are required to validate these findings and explore alternative treatments for CUA.
Abstract:
Background. Calcific uremic arteriolopathy (CUA) or calciphylaxis though generally noted for its high mortality, recent case reports have shown promising results using single agent therapies. However, it is not clear whether combination therapeutic agents will improve course of the disease. Objective. To determine clinical outcome in subjects with CUA on multimodal treatment. Methods. All patients with end-stage renal failure (ESRF) at The Townsville Hospital, Australia, from April 1, 2006, to March 31, 2011, with diagnosis of CUA were retrospectively studied. Results. Six subjects with CUA (4 females and 2 males) were on various combination therapeutic agents comprising sodium thiosulphate, hyperbaric oxygen, prednisolone, cinacalcet, and parathyroidectomy in addition to intensified haemodialysis, specialist local wound care, and antibiotics. The wounds failed to heal in 3 patients while 5 of the 6 subjects died; cause of death being sepsis in 3 and myocardial infarction in 2. Conclusion. Prognosis of CUA remains poor in spite of multimodal combination therapy. Further prospective studies on a larger population are needed to verify our findings.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Peripheral Artery Disease III: Interprofessional Care
Urinary Tract Calculi III: Medical Management
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care
